Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ClaritevCTEV -3.69%66 EV-to-OCF is 50.26 as of Aug. 02, 2026, which is 82% above its 10-year median of 27.64. GuruFocus rates CTEV with a GF Score™ of 66/100 and a GF Value™ of $31.35 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Claritev ranks worse than 92.53% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Claritev's Enterprise Value is $5,106.5 Mil.
Claritev's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $101.6 Mil. Therefore, Claritev's EV-to-OCF for today is 50.26.
The historical rank and industry rank for Claritev's EV-to-OCF or its related term are showing as below:
CTEV'
s EV-to-OCF Range Over the Past 10 Years
Min: 13.73 Med: 27.64 Max: 491.38
Current: 50.26
During the past 8 years, the highest EV-to-OCF of Claritev was 491.38. The lowest was 13.73. And the median was 27.64.
CTEV's EV-to-OCF is ranked worse than 92.53% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 8.64
vs CTEV: 50.26
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Claritev's share price for today is $22.71.
Claritev's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.330.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Claritev EV-to-OCF Related Terms
Claritev EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Claritev's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Claritev's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Claritev EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Claritev's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Claritev's EV-to-OCF falls into.
Claritev's current Enterprise Value is $5,106.5 Mil.
Claritev's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $101.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Claritev (CTEV) has a EV-to-OCF of 50.26 as of Aug. 02, 2026. This is 82% above median its historical median of 27.64. Over the past decade, Claritev's EV-to-OCF has ranged from 13.73 to 491.38. According to the industry distribution chart, Claritev ranks #632 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 92.5%.
Is Claritev's EV-to-OCF too high?
Claritev's current EV-to-OCF of 50.26 is 82% above median its 10-year median of 27.64. Over the past 10 years, this metric has ranged from a low of 13.73 to a high of 491.38. The Healthcare Providers & Services industry median EV-to-OCF is 8.64. Claritev's value of 50.26 is 481.7% above this industry median. Based on the distribution chart, Claritev ranks #632 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Claritev has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Claritev's EV-to-OCF compare to SLP and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Claritev ranks #632 out of 683 companies for EV-to-OCF. This places Claritev in the lower half of its industry. The industry median EV-to-OCF is 8.64. Claritev's value of 50.26 is 481.7% above this benchmark. Historically, Claritev's own EV-to-OCF has ranged from 13.73 to 491.38 over the past decade. While the company's 10-year median is 27.64 vs. the industry median of 8.64, Claritev has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.64, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Claritev's current EV-to-OCF of 50.26 is 481.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Claritev's current EV-to-OCF is 50.26, which is 82% above median its own 10-year median of 27.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Claritev stock overvalued right now?
Based on GuruFocus' analysis, Claritev (CTEV) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.35, compared to a current price of $22.71 — trading 27.6% below its estimated fair value. The current EV-to-OCF is 50.26, which is 82% above median its 10-year median of 27.64 and 481.7% above the Healthcare Providers & Services industry median of 8.64. Claritev's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Claritev (CTEV), the current EV-to-OCF is 50.26 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Claritev (CTEV) Overvalued in 2026?
Based on GuruFocus' analysis, Claritev stock appears to be undervalued.
The current stock price of $22.71 is trading 27.6% below its estimated GF Value™ of $31.35.
GuruFocus considers Claritev to be Modestly Undervalued.
Key valuation signals for CTEV:
EV-to-OCF: 50.26 (82% above median its 10-year median of 27.64)
GF Value™: $31.35 vs. price of $22.71 (27.6% below fair value)
Industry Position: 481.7% above the Healthcare Providers & Services median (#632 of 683)
No single metric tells the full story. See the CTEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
66GF Score
Get the complete analysis for CTEV
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CTEV has been successfully added to your 
